ATAI Life Sciences NV (MEX:ATAI) Dividend Payout Ratio : 0.00 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is ATAI Life Sciences NV Dividend Payout Ratio?

ATAI Life Sciences NV's dividend payout ratio for the months ended in Mar. 2024 was 0.00.

The historical rank and industry rank for ATAI Life Sciences NV's Dividend Payout Ratio or its related term are showing as below:

MEX:ATAI's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.435
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-24), the Dividend Yield % of ATAI Life Sciences NV is 0.00%.

ATAI Life Sciences NV's Dividends per Share for the months ended in Mar. 2024 was MXN0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

ATAI Life Sciences NV Dividend Payout Ratio Historical Data

The historical data trend for ATAI Life Sciences NV's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ATAI Life Sciences NV Dividend Payout Ratio Chart

ATAI Life Sciences NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dividend Payout Ratio

ATAI Life Sciences NV Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Dividend Payout Ratio	Get a 7-Day Free Trial													-	-	-	-	-

Competitive Comparison of ATAI Life Sciences NV's Dividend Payout Ratio

For the Biotechnology subindustry, ATAI Life Sciences NV's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ATAI Life Sciences NV's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ATAI Life Sciences NV's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where ATAI Life Sciences NV's Dividend Payout Ratio falls into.

ATAI Life Sciences NV Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

ATAI Life Sciences NV's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2023 )	/	EPS without NRI (A: Dec. 2023 )
	=	0	/	-11.941
	=	N/A

ATAI Life Sciences NV's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2024 )	/	EPS without NRI (Q: Mar. 2024 )
	=	0	/	-2.673
	=	N/A

ATAI Life Sciences NV (MEX:ATAI) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

ATAI Life Sciences NV Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of ATAI Life Sciences NV's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

ATAI Life Sciences NV (MEX:ATAI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ATAI Life Sciences NV (MEX:ATAI) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

ATAI:USA 9VC:Germany

Address

Wallstraße 16, Berlin, BB, DEU, 10179

Website

https://www.atai.life

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.